Fennec Pharmaceuticals Stock Price on December 18, 2024
| FENC Stock | USD 6.20 0.21 3.51% |
Below is the normalized historical share price chart for Fennec Pharmaceuticals extending back to November 12, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Fennec Pharmaceuticals stands at 6.20, as last reported on the 24th of December, with the highest price reaching 6.20 and the lowest price hitting 5.73 during the day.
If you're considering investing in Fennec Stock, it is important to understand the factors that can impact its price. Fennec Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Fennec Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0954, which denotes the company had a 0.0954% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Fennec Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please utilize Fennec Pharmaceuticals' Downside Deviation of 4.11, mean deviation of 3.43, and Coefficient Of Variation of 1569.8 to check if our risk estimates are consistent with your expectations.
At present, Fennec Pharmaceuticals' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 5.6 M, whereas Total Stockholder Equity is projected to grow to (11 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 0.53, whereas Price To Sales Ratio is forecasted to decline to 13.33. Fennec Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of June 2001 | 200 Day MA 6.7079 | 50 Day MA 5.0846 | Beta 0.267 |
Fennec |
Sharpe Ratio = 0.0954
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FENC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.61 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.44 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Fennec Pharmaceuticals is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fennec Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 57.9258 | Enterprise Value Ebitda 51.691 | Price Sales 3.3298 | Shares Float 14.9 M | Wall Street Target Price 13.6 |
Fennec Pharmaceuticals Main Headline on 18th of December 2024
Disposition of 400000 shares by Hackman Jeffrey S. of Fennec... by Hackman Jeffrey S.
Filed transaction by Fennec Pharmaceuticals Director, Officer Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Fennec Pharmaceuticals Valuation on December 18, 2024
It is possible to determine the worth of Fennec Pharmaceuticals on a given historical date. On December 18, 2024 Fennec was worth 6.05 at the beginning of the trading date compared to the closed value of 5.66. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Fennec Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Fennec Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fennec Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Fennec Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 5.86 | 6.17 | 5.84 | 6.07 | 80,629 | |
12/18/2024 | 6.05 | 6.14 | 5.59 | 5.66 | 104,169 |
| 5.69 | 5.96 | 5.51 | 5.84 | 77,409 |
| Backtest Fennec Pharmaceuticals | | | Fennec Pharmaceuticals History | | | Fennec Pharmaceuticals Valuation | Previous | Next |
Fennec Pharmaceuticals Trading Date Momentum on December 18, 2024
| On December 19 2024 Fennec Pharmaceuticals was traded for 5.84 at the closing time. The top price for the day was 5.96 and the lowest listed price was 5.51 . The trading volume for the day was 77.4 K. The trading history from December 19, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 3.18% . The overall trading delta against the current closing price is 5.83% . |
Fennec Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Fennec Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Fennec Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Fennec financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Fennec Pharmaceuticals Stock history
Fennec Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fennec is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fennec Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fennec Pharmaceuticals stock prices may prove useful in developing a viable investing in Fennec Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.6 M | 27.9 M | |
| Net Loss | -21.3 M | -20.3 M |
Fennec Pharmaceuticals Quarterly Net Working Capital |
|
Fennec Pharmaceuticals Stock Technical Analysis
Fennec Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Fennec Pharmaceuticals Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Fennec Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Fennec Pharmaceuticals December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Fennec Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fennec Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Fennec Pharmaceuticals stock market strength indicators, traders can identify Fennec Pharmaceuticals entry and exit signals to maximize returns
Fennec Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Fennec Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Fennec Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fennec to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0587 | |||
| Jensen Alpha | 0.261 | |||
| Total Risk Alpha | 0.1467 | |||
| Sortino Ratio | 0.0624 | |||
| Treynor Ratio | 0.3463 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |